Vioxx News

Vioxx Heart Safety Study Cancelled by Merck

At a glance:

Evidence presented in the current Vioxx trial going on in New Jersey, suggests that Merck cancelled a study of the drug's heart safety the day after a labelling issue was settled with the FDA. 
 
A Merck official testified that the timing was a coincidence. 
 
Evidence was also presented concerning Merck's efforts to counterbalance doctors' concerns about Vioxx safety. These included paying doctors to serve on advisory boards or to participate in studies.


Lawyer: Merck Scrapped Study on Vioxx

MSN Money - 6/16/2006 4:00 PM

ATLANTIC CITY, N.J. (AP) - Merck & Co. scrapped a planned study of the cardiac safety of Vioxx once it knew U.S. regulators were going to tone down their warning about heart risks for patients taking the painkiller, a plaintiff's lawyer argued Friday in a product liability trial.
 
But Merck's former head of U.S. marketing, David Anstice, testified it was coincidence that the study was canceled in March 2002 as Food and Drug Administration regulators and Merck officials settled on putting a notice about Vioxx cardiac risks in the precautions section of the drug's label -- the fine-print package insert -- rather than in the higher-profile warnings section

 
· Read The Full Vioxx Article From MSN Money -->

· Read All Vioxx (Rofecoxib) News Stories -->

Comments On Vioxx News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: